Market News AIOpen the app

VRTX stock news · Vertex Pharmaceuticals

Stories about Vertex Pharmaceuticals (VRTX) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for VRTX

Follow Vertex Pharmaceuticals (VRTX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for VRTX
Free on the App Store and Google Play, or on the web.
  1. Oct 30, 2026, 7:04 AM ET · Market

    The UK has allowed Vertex Pharmaceuticals to use its Casgevy gene therapy for kids five and up.

    Good for VRTX

    Casgevy is now approved in the UK for children aged 5 and older, expanding the group it can treat. This is favorable for Vertex.

  2. Sep 29, 2026, 1:41 PM ET · Market

    Big trades in 10 health care stocks happened today.

    Neutral

    Vertex had a call trade labeled bullish. This reports trader activity, not a change in Vertex's business, so it does not change its outlook.

  3. Aug 21, 2026, 8:29 AM ET · Market

    CNBC’s ‘Final Trades’ features Uber, ServiceNow, and a notable health care stock.

    Good for VRTX

    Vertex reported better-than-expected earnings and raised its FY2026 sales guidance.